Corvo, Alessandra
Avril, Stéphane https://orcid.org/0000-0002-8604-7736
Aliseda, Alberto
Haulon, Stéphan
Chassagne, Fanette
Funding for this research was provided by:
Agence Nationale de la Recherche (ANR-21-RHUS-0011)
Article History
Received: 10 March 2025
Accepted: 5 July 2025
First Online: 22 July 2025
Declarations
:
: The author(s) declared the following potential Conflict of interest with respect to the research, authorship, and/or publication of this article: Stephan Haulon is a consultant and has IP with Cook Medical and GE Healthcare. Stéphane Avril is cofounder of Predisurge, France.
: Patients were enrolled in a study (clinical trials NCT04724863) between April 2020 and January 2021 (Aortic Center, Marie Lannelongue Hospital, Paris, France). The clinical trial NCT04724863 was approved by the ethical review boards, as required by law, following the Declaration of Helsinki, which outlines ethical principles for medical research involving human participants.
: All participants were informed of the procedures and provided written informed consent.